Combined proteomics and CRISPR‒Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivo.
Bahrami E, Schmid JP, Jurinovic V, Becker M, Wirth AK, Ludwig R, Kreissig S, Duque Angel TV, Amend D, Hunt K, Öllinger R, Rad R, Frenz JM, Solovey M, Ziemann F, Mann M, Vick B, Wichmann C, Herold T, Jayavelu AK, Jeremias I.
Bahrami E, et al. Among authors: wichmann c.
Mol Cancer. 2023 Jul 8;22(1):107. doi: 10.1186/s12943-023-01803-0.
Mol Cancer. 2023.
PMID: 37422628
Free PMC article.